2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 127083 |
MeSH ID | M0173965 |
Synonym |
---|
98119-88-1 |
ethyl 2-(2-phenylthiazolo(3,2-b)(1,2,4)triazol-6-yl)-4-thiazolecarboxylate |
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole |
4-thiazolecarboxylic acid, 2-(2-phenylthiazolo(3,2-b)(1,2,4)triazol-6-yl)-, ethyl ester |
DTXSID50913439 |
ethyl 2-(2-phenyl[1,3]thiazolo[3,2-b][1,2,4]triazol-6-yl)-1,3-thiazole-4-carboxylate |
OHFGWCTVJHPJMY-UHFFFAOYSA-N |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 7 (63.64) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.40) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (18.18%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (81.82%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |